InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding InMed Pharmaceuticals Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 14 | −4 |
| Shares | 685.9K | 440.3K | −245.6K (−35.8%) |
| Value | $249.2K | $116.6K | −$132.6K (−53.2%) |
New holders (4)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 86,684 | $23.0K | 0.00% |
| XTX Topco Ltd | 17,819 | $4.73K | 0.00% |
| HRT Financial LP | 15,996 | $4.00K | 0.00% |
| TD Waterhouse Canada Inc. | 85 | $21 | 0.00% |
Sold out (8)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Armistice Capital, LLC | 266,968 | $97.2K |
| Renaissance Technologies LLC | 28,300 | $10.0K |
| Two Sigma Securities, LLC | 15,423 | $5.61K |
| BFSG, LLC | 200 | $73 |
| AdvisorNet Financial, Inc | 80 | $29 |
| UBS Group AG | 41 | $15 |
| Federation des caisses Desjardins du Quebec | 19 | $7 |
| National Bank of Canada | 12 | $3 |